Literature DB >> 16530768

Selective effect of conjugated linoleic acid isomers on atherosclerotic lesion development in apolipoprotein E knockout mice.

José M Arbonés-Mainar1, María A Navarro, Mario A Guzmán, Carmen Arnal, Joaquín C Surra, Sergio Acín, Ricardo Carnicer, Jesús Osada, Helen M Roche.   

Abstract

Research suggests that conjugated linoleic acid (CLA) may inhibit atherosclerosis, but there are contradictory results in different animal models fed heterogeneous mixtures of CLA isomers. This study addressed the hypothesis that the individual CLA isomers may exert different atherogenic properties. ApoE(-/-) mice were fed isocaloric, isonitrogenous westernized diets containing 0.15% cholesterol and enriched with 1% (w/w) cis-9,trans-11-CLA (c9,t11-CLA), trans-10,cis-12-CLA (t10,c12-CLA) or linoleic acid (control diet) for 12 weeks. At the end of the dietary intervention, the effects of CLA isomers on the development of atherosclerotic vascular lesions, lipid metabolism, inflammation and oxidative stress were assessed. The t10,c12-CLA diet had a profound pro-atherogenic effect, whereas c9,t11-CLA impeded the development of atherosclerosis. En face aortic lesion assessment showed more dorsal and lumbar extensions presenting atherosclerotic foci after the t10,c12-CLA diet. Furthermore, animals fed t10,c12-CLA had pronounced hyperlipidemia, higher 8-iso-prostaglandin F(2alpha) levels, higher vulnerable atherosclerotic plaque with a lower smooth muscle and fibre contents and higher macrophage content and activation, assayed as plasma chitotriosidase compared to the control or c9,t11-CLA dietary groups. Plasma chitotriosidase activity was more closely associated with the extent of the plaque than with MOMA staining or than monocyte chemoattractant protein-1 levels. Our results demonstrate that CLA isomers differentially modulate the development of atherosclerosis, c9,t11-CLA impedes, whereas t10,c12-CLA promotes atherosclerosis. These opposing effects may be ascribed to divergent effects on lipid, oxidative, inflammatory and fibro muscular components of this pathology. Plasma chitotriosidase is a better indicator of dietary fat interventions that alter plaque monocyte activity in this murine model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16530768     DOI: 10.1016/j.atherosclerosis.2006.01.015

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  21 in total

1.  Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus.

Authors:  Alper Sonmez; Cem Haymana; Serkan Tapan; Umut Safer; Gurkan Celebi; Ozlem Ozturk; Halil Genc; Teoman Dogru; Ilker Tasci; Gokhan Erdem; Abdullah Taslipinar; Aydogan Aydogdu; Mahmut I Yilmaz; Ismail Kurt; Mustafa Kutlu
Journal:  Endocrine       Date:  2010-04-11       Impact factor: 3.633

2.  Ozone-induced dissociation of conjugated lipids reveals significant reaction rate enhancements and characteristic odd-electron product ions.

Authors:  Huong T Pham; Alan T Maccarone; J Larry Campbell; Todd W Mitchell; Stephen J Blanksby
Journal:  J Am Soc Mass Spectrom       Date:  2013-01-05       Impact factor: 3.109

Review 3.  Effects of ruminant trans fatty acids on cardiovascular disease and cancer: a comprehensive review of epidemiological, clinical, and mechanistic studies.

Authors:  Sarah K Gebauer; Jean-Michel Chardigny; Marianne Uhre Jakobsen; Benoît Lamarche; Adam L Lock; Spencer D Proctor; David J Baer
Journal:  Adv Nutr       Date:  2011-06-28       Impact factor: 8.701

4.  Polymerase I and transcript release factor (PTRF) regulates adipocyte differentiation and determines adipose tissue expandability.

Authors:  Sergio Perez-Diaz; Lance A Johnson; Robert M DeKroon; Jose M Moreno-Navarrete; Oscar Alzate; Jose M Fernandez-Real; Nobuyo Maeda; Jose M Arbones-Mainar
Journal:  FASEB J       Date:  2014-05-08       Impact factor: 5.191

5.  Nitric oxide-releasing agent, LA419, reduces atherogenesis in apolipoprotein E-deficient mice.

Authors:  Ricardo Carnicer; Natalia Guillén; José M Arbonés-Mainar; María A Navarro; Mario A Guzmán; Cristina Barranquero; Carmen Arnal; Sonia Gascón; Sergio Acín; Marisabel Mourelle; Jesús Osada
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-12-03       Impact factor: 3.000

6.  Effect of a high intake of conjugated linoleic acid on lipoprotein levels in healthy human subjects.

Authors:  Anne J Wanders; Ingeborg A Brouwer; Els Siebelink; Martijn B Katan
Journal:  PLoS One       Date:  2010-02-03       Impact factor: 3.240

Review 7.  Atheroprotective effects of conjugated linoleic acid.

Authors:  Robyn Bruen; Stephen Fitzsimons; Orina Belton
Journal:  Br J Clin Pharmacol       Date:  2016-05-07       Impact factor: 4.335

8.  Plasma chitotriosidase and carotid intima-media thickness in children with sickle cell disease.

Authors:  Normeen A Kaddah; Dalia A Saied; Hanan A Alwakeel; Rania H Hashem; Sara M Rowizak; Mohamed A Elmonem
Journal:  Int J Hematol       Date:  2017-07-04       Impact factor: 2.490

9.  Effect of conjugated linoleic acid, vitamin E and their combination on lipid profiles and blood pressure of Iranian adults with active rheumatoid arthritis.

Authors:  Naheed Aryaeian; Farhad Shahram; Mahmoud Djalali; Mohammad R Eshragian; Abolghasem Djazayeri; Abdolfatah Sarrafnejad; Nasim Naderi; Maryam Chamari; Fariha Fatehi; Mahnaz Zarei
Journal:  Vasc Health Risk Manag       Date:  2008

10.  Isomer specificity of conjugated linoleic acid (CLA): 9E,11E-CLA.

Authors:  Yunkyoung Lee
Journal:  Nutr Res Pract       Date:  2008-12-31       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.